Item 1.01 Entry into a Material Definitive Agreement.
On December 31, 2021, America Great Health (the "Company") entered into a
Supplementary Agreement with Zhigong Lin to amend his prior employment agreement
with the Company dated August 31, 2021. The Supplement Agreements provides,
inter alia, that Lin will be appointed Chief Executive Officer of GOF
Biotechnologies, Inc., a newly-incorporated majority-owned subsidiary of the
Company and Lin's monthly compensation will be adjusted to $6,000 beginning
December 1, 2021 and to $8,000 from January 1, 2022.
The preceding description of the Supplementary Agreement does not purport to be
complete and is qualified in its entirety by reference to the Supplementary
Agreement, which is filed as Exhibit 10.1 to this report and incorporated herein
by reference.
Item 8.01 Other Events.
On November 4, 2021, the Company incorporated a wholly-owned subsidiary, GOF
Biotechnologies, Inc. ("GOF") in the State of California. GOF is 75% majority
owned (60,000,000 shares of common stock) by the Company and the remaining 25%
of its issued and outstanding shares (20,000,000 shares of common stock) are
held by Men Hwei, Tsai.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
10.1 Lin Supplementary Agreement dated December 31, 2021.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
AMERICA GREAT HEALTH 
